These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 18316821

  • 1. Recovery of antimicrobial-resistant Pseudomonas aeruginosa from sputa of cystic fibrosis patients by culture on selective media.
    Perry JD, Laine L, Hughes S, Nicholson A, Galloway A, Gould FK.
    J Antimicrob Chemother; 2008 May; 61(5):1057-61. PubMed ID: 18316821
    [Abstract] [Full Text] [Related]

  • 2. A novel chromogenic medium for isolation of Pseudomonas aeruginosa from the sputa of cystic fibrosis patients.
    Laine L, Perry JD, Lee J, Oliver M, James AL, De La Foata C, Halimi D, Orenga S, Galloway A, Gould FK.
    J Cyst Fibros; 2009 Mar; 8(2):143-9. PubMed ID: 19097827
    [Abstract] [Full Text] [Related]

  • 3. Antimicrobial use and Pseudomonas aeruginosa susceptibility profile in a cystic fibrosis centre.
    Manno G, Cruciani M, Romano L, Scapolan S, Mentasti M, Lorini R, Minicucci L.
    Int J Antimicrob Agents; 2005 Mar; 25(3):193-7. PubMed ID: 15737511
    [Abstract] [Full Text] [Related]

  • 4. Variable antibiotic susceptibility in populations of Pseudomonas aeruginosa infecting patients with bronchiectasis.
    Gillham MI, Sundaram S, Laughton CR, Haworth CS, Bilton D, Foweraker JE.
    J Antimicrob Chemother; 2009 Apr; 63(4):728-32. PubMed ID: 19193658
    [Abstract] [Full Text] [Related]

  • 5. Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbation of cystic fibrosis and its impact on the validity of antimicrobial susceptibility testing.
    Foweraker JE, Laughton CR, Brown DF, Bilton D.
    J Antimicrob Chemother; 2005 Jun; 55(6):921-7. PubMed ID: 15883175
    [Abstract] [Full Text] [Related]

  • 6. Changes in cystic fibrosis sputum microbiology in the United States between 1995 and 2008.
    Emerson J, McNamara S, Buccat AM, Worrell K, Burns JL.
    Pediatr Pulmonol; 2010 Apr; 45(4):363-70. PubMed ID: 20232473
    [Abstract] [Full Text] [Related]

  • 7. Facilitated detection of antibiotic-resistant Pseudomonas in cystic fibrosis sputum using homogenized specimens and antibiotic-containing media.
    Maduri-Traczewski M, L'Heureux C, Escalona L, Macone A, Goldmann D.
    Diagn Microbiol Infect Dis; 1986 Nov; 5(4):299-305. PubMed ID: 3096628
    [Abstract] [Full Text] [Related]

  • 8. [Pseudomonas aeruginosa: antimicrobial resistance in clinical isolates. Castellón 2004-2008].
    Pardo Serrano FJ, Tirado Balaguer MD, García Zúñiga ED, Granados Ortega J, Campos Aznar A, Moreno Muñoz R.
    Rev Esp Quimioter; 2010 Mar; 23(1):20-6. PubMed ID: 20232020
    [Abstract] [Full Text] [Related]

  • 9. Development of selective media for the isolation of yeasts and filamentous fungi from the sputum of adult patients with cystic fibrosis (CF).
    Nagano Y, Millar BC, Goldsmith CE, Walker JM, Elborn JS, Rendall J, Moore JE.
    J Cyst Fibros; 2008 Nov; 7(6):566-72. PubMed ID: 18723404
    [Abstract] [Full Text] [Related]

  • 10. [Evolution of antimicrobial resistance against Pseudomonas aeruginosa in a French university hospital between 2002 and 2006].
    Minchella A, Molinari L, Alonso S, Bouziges N, Sotto A, Lavigne JP.
    Pathol Biol (Paris); 2010 Feb; 58(1):1-6. PubMed ID: 19875241
    [Abstract] [Full Text] [Related]

  • 11. Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: second national study (2003).
    Sánchez-Romero I, Cercenado E, Cuevas O, García-Escribano N, García-Martínez J, Bouza E, Spanish Group for Study of Pseudomonas aeruginosa.
    Rev Esp Quimioter; 2007 Jun; 20(2):222-9. PubMed ID: 17893760
    [Abstract] [Full Text] [Related]

  • 12. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
    Hill D, Rose B, Pajkos A, Robinson M, Bye P, Bell S, Elkins M, Thompson B, Macleod C, Aaron SD, Harbour C.
    J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967
    [Abstract] [Full Text] [Related]

  • 13. Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates.
    Cantón R, Valdezate S, Vindel A, Sánchez Del Saz B, Maíz L, Baquero F.
    Pediatr Pulmonol; 2003 Feb; 35(2):99-107. PubMed ID: 12526070
    [Abstract] [Full Text] [Related]

  • 14. Direct antimicrobial susceptibility testing method for analysis of sputum collected from patients with cystic fibrosis.
    Zebouh M, Thomas C, Honderlick P, Lemee L, Segonds C, Wallet F, Husson MO.
    J Cyst Fibros; 2008 May; 7(3):238-43. PubMed ID: 18498727
    [Abstract] [Full Text] [Related]

  • 15. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa.
    Al-Jasser AM, Elkhizzi NA.
    Saudi Med J; 2004 Jun; 25(6):780-4. PubMed ID: 15195211
    [Abstract] [Full Text] [Related]

  • 16. Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients.
    Hogardt M, Schmoldt S, Götzfried M, Adler K, Heesemann J.
    J Antimicrob Chemother; 2004 Dec; 54(6):1057-61. PubMed ID: 15509615
    [Abstract] [Full Text] [Related]

  • 17. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.
    Bradbury R, Champion A, Reid DW.
    Respirology; 2008 Nov; 13(6):886-92. PubMed ID: 18811887
    [Abstract] [Full Text] [Related]

  • 18. Antimicrobial susceptibility of Pseudomonas aeruginosa before and after initiation of inhaled tobramycin in Bulgaria.
    Petrova G, Strateva T, Miteva D, Lazova S, Perenovska P.
    J Infect Dev Ctries; 2016 Nov 24; 10(11):1265-1267. PubMed ID: 27886041
    [Abstract] [Full Text] [Related]

  • 19. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
    Alişkan H, Colakoğlu S, Turunç T, Demiroğlu YZ, Erdoğan F, Akin S, Arslan H.
    Mikrobiyol Bul; 2008 Apr 24; 42(2):321-9. PubMed ID: 18697430
    [Abstract] [Full Text] [Related]

  • 20. Combination testing of multidrug-resistant cystic fibrosis isolates of Pseudomonas aeruginosa: use of a new parameter, the susceptible breakpoint index.
    Milne KE, Gould IM.
    J Antimicrob Chemother; 2010 Jan 24; 65(1):82-90. PubMed ID: 19861334
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.